Showing results (41-50 of 91) with videos related to
Sort By:
Pageof 10
Seminars in Immunology|September 5, 2017
Nanoparticles and innate immunity: new perspectives on host defenceDiana Boraschi, Paola Italiani, Roberto Palomba, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2005
A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapyS Moein Moghimi, Peter Symonds, J Clifford Murray, et al.Advanced Drug Delivery Reviews|May 29, 2012
Genomic perspectives in inter-individual adverse responses following nanomedicine administration: The way forwardS Moein Moghimi, Peter P Wibroe, Shen Y Helvig, et al.FEBS Letters|October 26, 2005
Low and high molecular weight poly(L-lysine)s/poly(L-lysine)-DNA complexes initiate mitochondrial-mediated apoptosis differentlyPeter Symonds, J Clifford Murray, A Christy Hunter, et al.Journal of Biomedical Nanotechnology|January 9, 2010
Complement: alive and kicking nanomedicinesAlina J Andersen, S Hossein Hashemi, Thomas L Andresen, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 4, 2012
The possible "proton sponge " effect of polyethylenimine (PEI) does not include change in lysosomal pHRikke V Benjaminsen, Maria A Mattebjerg, Jonas R Henriksen, et al.Mitochondrion|September 20, 2011
Polyethylenimine-mediated impairment of mitochondrial membrane potential, respiration and membrane integrity: implications for nucleic acid delivery and gene therapyAnna K Larsen, Dominika Malinska, Izabela Koszela-Piotrowska, et al.Biochimica Et Biophysica Acta|July 16, 2013
High resolution respirometry analysis of polyethylenimine-mediated mitochondrial energy crisis and cellular stress: Mitochondrial proton leak and inhibition of the electron transport systemArnaldur Hall, Anna K Larsen, Ladan Parhamifar, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 10, 2023
Activation of the complement system by nanoparticles and strategies for complement inhibitionHajira B Haroon, Elisha Dhillon, Z Shadi Farhangrazi, et al.Biochimica Et Biophysica Acta|June 16, 2004
Causative factors behind poloxamer 188 (Pluronic F68, Flocor)-induced complement activation in human sera. A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levelsS Moein Moghimi, A Christy Hunter, Christopher M Dadswell, et al.Pageof 10